HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Francesco Verderame Selected Research
Francesco Verderame Research Topics
Disease
8
Neoplasms (Cancer)
03/2024 - 06/2018
7
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 02/2003
6
Prostatic Neoplasms (Prostate Cancer)
12/2019 - 01/2015
5
Breast Neoplasms (Breast Cancer)
01/2022 - 07/2006
4
Neoplasm Metastasis (Metastasis)
03/2024 - 01/2015
3
Hepatocellular Carcinoma (Hepatoma)
03/2024 - 11/2023
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 11/2019
3
Triple Negative Breast Neoplasms
02/2024 - 09/2023
3
Human Influenza (Influenza)
11/2023 - 01/2020
2
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 03/2006
2
Brain Neoplasms (Brain Tumor)
06/2022 - 01/2019
2
Neutropenia
01/2021 - 09/2008
2
Febrile Neutropenia
01/2021 - 09/2008
1
Mesothelioma
02/2024
1
Lung Neoplasms (Lung Cancer)
12/2023
1
Disease Progression
11/2023
1
Heart Arrest (Cardiac Arrest)
01/2021
1
Multiple Organ Failure (MODS)
01/2021
1
Enterocolitis
01/2021
1
Dehydration (Water Stress)
01/2021
1
Pancytopenia
01/2021
1
Sudden Death
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Pulmonary Embolism
01/2021
1
Respiratory Insufficiency (Respiratory Failure)
01/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Sepsis (Septicemia)
01/2021
1
Hepatitis
01/2021
1
COVID-19
01/2020
1
Osteolysis
04/2018
1
Hemangiosarcoma (Angiosarcoma)
03/2017
1
Adenocarcinoma
03/2006
Drug/Important Bio-Agent (IBA)
5
Nivolumab
IBA
02/2024 - 01/2019
5
Immune Checkpoint Inhibitors
IBA
11/2023 - 01/2020
5
Vinorelbine (Navelbine)
FDA Link
Generic
01/2020 - 02/2003
4
Etoposide (VP 16)
FDA Link
Generic
02/2024 - 11/2019
4
Platinum
IBA
06/2022 - 01/2019
4
Docetaxel (Taxotere)
FDA Link
02/2016 - 04/2014
3
Paclitaxel (Taxol)
FDA Link
Generic
02/2024 - 09/2023
3
durvalumab
IBA
06/2022 - 11/2019
3
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 02/2003
3
Abiraterone Acetate
IBA
02/2016 - 05/2015
2
atezolizumab
IBA
02/2024 - 09/2023
2
Carboplatin (JM8)
FDA Link
Generic
02/2024 - 01/2021
2
Biomarkers (Surrogate Marker)
IBA
02/2024 - 12/2023
2
Gemcitabine
FDA Link
04/2014 - 02/2003
1
Yttrium-90
IBA
03/2024
1
Sorafenib (BAY 43-9006)
FDA Link
02/2024
1
130-nm albumin-bound paclitaxel
IBA
09/2023
1
ribociclib
IBA
01/2022
1
Epidermal Growth Factor (EGF)
IBA
01/2022
1
Hormones (Hormone)
IBA
01/2022
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
01/2022
1
Aromatase Inhibitors
IBA
01/2022
1
Influenza Vaccines (Influenza Vaccine)
FDA Link
01/2021
1
tremelimumab
IBA
01/2021
1
Radium-223
IBA
12/2019
1
eribulin
FDA Link
01/2019
1
Therapeutic Uses
IBA
04/2018
1
Radiopharmaceuticals
IBA
04/2018
1
Radium
IBA
04/2018
1
enzalutamide
IBA
07/2015
1
cabazitaxel
FDA Link
07/2015
1
nas
IBA
07/2015
1
abiraterone
IBA
01/2015
1
Trastuzumab (Herceptin)
FDA Link
04/2014
1
Acids
IBA
07/2006
1
Fluorouracil (Carac)
FDA Link
Generic
07/2006
1
Cetuximab (Erbitux)
FDA Link
03/2006
1
Irinotecan (Camptosar)
FDA Link
Generic
03/2006
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
03/2006
1
Ifosfamide
FDA Link
Generic
02/2003
Therapy/Procedure
10
Therapeutics
12/2023 - 03/2006
5
Castration
12/2019 - 01/2015
5
Drug Therapy (Chemotherapy)
01/2019 - 03/2006
4
Immunotherapy
02/2024 - 01/2020
2
Radiotherapy
06/2022 - 12/2019
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2018 - 03/2017
1
Investigational Therapies (Experimental Therapy)
12/2023
1
Cranial Irradiation
06/2022
1
Off-Label Use
04/2018
1
Intravenous Infusions
03/2006